SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016869
Filing Date
2022-08-11
Accepted
2022-08-11 16:11:22
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q grph-20220630.htm   iXBRL 10-Q 3329349
2 EX-31.1 grph-ex31_1.htm EX-31.1 20662
3 EX-31.2 grph-ex31_2.htm EX-31.2 21066
4 EX-32.1 grph-ex32_1.htm EX-32.1 12034
5 EX-32.2 grph-ex32_2.htm EX-32.2 11878
  Complete submission text file 0000950170-22-016869.txt   10437207

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grph-20220630.xsd EX-101.SCH 63848
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grph-20220630_lab.xml EX-101.LAB 507924
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grph-20220630_def.xml EX-101.DEF 244434
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grph-20220630_cal.xml EX-101.CAL 42007
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grph-20220630_pre.xml EX-101.PRE 386735
66 EXTRACTED XBRL INSTANCE DOCUMENT grph-20220630_htm.xml XML 1717652
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40532 | Film No.: 221155894
SIC: 2836 Biological Products, (No Diagnostic Substances)